Navigation Links
Alexza Pharmaceuticals Completes End-of-Review Meeting With FDA for AZ-004 (Staccato® Loxapine) NDA
Date:1/18/2011

eview period will be 6 months.

The CRL also raised issues relating to the suitability of the stability studies undertaken by Alexza and certain other items relating to the Agency's pre-approval manufacturing inspection, which was completed in August 2010.  Alexza believes it understands these issues and that the issues can be adequately addressed in the AZ-004 NDA resubmission.

Since AZ-004 incorporates a novel delivery system, the CRL included input from FDA's Center for Devices and Radiological Health (CDRH).  In the CRL, CDRH requested a human factors study and related analysis to validate that the product can be used effectively in the proposed clinical setting.  Prior to the End-of-Review meeting, Alexza provided a human factors study draft protocol for review by CDRH, on which the FDA provided input and comments.  Alexza expects to finalize the protocol with the FDA and complete this study in the coming months.  Alexza is not required to conduct any additional efficacy or safety clinical trials.

CDRH also requested further bench testing of the product under an additional "worst-case" manufacturing scenario.  Alexza has completed this additional "worst-case" bench testing of the product, submitted data to the FDA and believes that this issue has been adequately addressed.

Conference Call Information

The Company will host an investor conference call and live webcast later today, Tuesday, January 18, 2011, at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time.  The conference call, live webcast and archived replay are open to all interested parties.

To access the conference call via the Internet, go to www.alexza.com, under the "Investor Relations" link.  Please join the call at least 15 minutes prior to the start of the call to ensure time for any software downloads that may be required.  Interested parties may also pre-regis
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine)
2. Alexza Pharmaceuticals Reports 2010 Third Quarter Financial Results and Provides Business Update
3. Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010
4. Alexza Pharmaceuticals Reacquires U.S. and Canadian Rights for AZ-004 (Staccato® Loxapine)
5. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
6. Alexza Pharmaceuticals Receives Complete Response Letter for AZ-004 (Staccato® Loxapine) NDA
7. Alexzas Staccato® Nicotine Licensed to Cypress Bioscience
8. Alexza Pharmaceuticals to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference
9. Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
10. Alexza to Announce 2010 Second Quarter Financial Results on Monday, July 26, 2010
11. Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... 2015 The global insulin market ... a new study by Grand View Research, Inc. Growing global prevalence ... high unmet needs in emerging markets such as India ... be two of the most significant growth drivers of this market. ... and growing global geriatric population base are expected to serve the ...
(Date:6/29/2015)... 29, 2015  VisionCare Ophthalmic Technologies, Inc. ... devices for the treatment of age-related macular ... "Long-Term (60-month) Results for the Implantable Miniature ... Age in Patients with End-Stage Age-Related Macular ... 5-year data show substantial retention of gains ...
(Date:6/29/2015)... Corporates today are on the ... CSR funds effectively.  A genuine step towards improving the ... would definitely interest them. And to make this possible, ... (MSC) to promote experiential learning.  STEM Learning is a ... India . So far, they have ...
Breaking Medicine Technology:Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 2Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 3Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 4Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 2Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 3Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 4Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 5Thinking of Innovative CSR Options? Partner With STEM Learning to Sponsor a Mini Science Centre 2Thinking of Innovative CSR Options? Partner With STEM Learning to Sponsor a Mini Science Centre 3
... $500 Million Senior Notes Offering in Connection With Agreement to... -- ARDEE, Ireland, Sept. 24 ... ... lpUnit=,PRN,; --> ... { var s = ,; var first_result; // Results are keyed by longUrl, so we need to ...
... 24 Stereotaxis, Inc. (Nasdaq: STXS ) today ... JMP Securities Healthcare Conference on Tuesday, September 28, 2010 at ... Officer, will provide an overview of the Company,s business strategy ... conference is by invitation only. A live audio and slides ...
Cached Medicine Technology:Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 2Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 3Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 4Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 5Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 6Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 7Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 8Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 9Stereotaxis to Present at the JMP Securities Healthcare Conference 2Stereotaxis to Present at the JMP Securities Healthcare Conference 3
(Date:6/29/2015)... (PRWEB) , ... June 29, 2015 , ... ... recognized by the independent auditor of customer service for the 40-center nursing home ... than 1,100 skilled nursing centers in the United States in one or more ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... a new approach to build nearly complete genomes by combining high-throughput DNA sequencing ... variation, critically important for their association with human disease, but previously difficult to ...
(Date:6/29/2015)... ... June 29, 2015 , ... With Urgent Care Medicine now serving a ... American Board of Urgent Care Medicine and the Medical Society of Delaware to provide ... Care physicians and health care professionals. , According to Matthew Bader, Exam Master CEO ...
(Date:6/29/2015)... ... 29, 2015 , ... USA Today reported on June 18th the ... Alabama. To impact the rest of the nation’s growing overdose death rates in 26 ... guidelines be followed to stop the increasing overdose trend from continuing: , ...
(Date:6/29/2015)... ... ... OR Manager announced Monday the launch of an enhanced http://www.ormanager.com . ... logo and weekly eLetter. The website contains the same informational articles, products, and resources ... , In addition to a refreshed look, http://www.ormanager.com now provides users ...
Breaking Medicine News(10 mins):Health News:National HealthCare Centers Receive 'Customer Experience Awards' 2Health News:National HealthCare Centers Receive 'Customer Experience Awards' 3Health News:National HealthCare Centers Receive 'Customer Experience Awards' 4Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 2Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 4Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 2Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 3Health News:Overdose Death Rates Decreased in Florida as of 2015 2Health News:Overdose Death Rates Decreased in Florida as of 2015 3Health News:OR Manager Launches New Website 2
... Goodwin HealthDay Reporter , THURSDAY, Feb. 17 ... no less likely to get injured than runners who ... investigate the effect of stretching on running injuries, researchers ... group stretched the quadriceps, hamstrings and calf muscles for ...
... Fractures Delaying Hip Fracture Surgery Appears Detrimental ... for both economic and humanitarian reasons Patients who wait ... fracture have a 39 percent rate of medical complication and ... rate. Patients who receive surgical treatment within 24 hours have ...
... Mo. Most people know that exercise is ... lifestyles and obesity rates are at all-time highs ... new study, University of Missouri researchers found that ... strategies significantly increased their physical activity levels. Conversely, ...
... 17 (HealthDay News) -- People who use the pesticides ... of developing Parkinson,s disease, a new study finds. ... 358 people without the nervous system disorder. All of ... Evaluation Study involving licensed pesticide applicators and their spouses. ...
... rinsing technique with betadine that costs just a little over ... following total knee and hip joint replacement surgery according to ... The study, presented at the American Association of Orthopedic ... betadine lavage combined with painting of the skin with a ...
... -- Some doctors post unethical and unprofessional content on ... oversight of physicians, use of social media, according to ... 260 U.S. physicians, each with 500 or more followers, ... This means the tweets included profanity, potential ...
Cached Medicine News:Health News:Pre-Run Stretching Doesn't Prevent Injuries, Study Finds 2Health News:Pre-Run Stretching Doesn't Prevent Injuries, Study Finds 3Health News:American Academy of Orthopaedic Surgeons 2011 Annual Meeting tip sheet 2Health News:American Academy of Orthopaedic Surgeons 2011 Annual Meeting tip sheet 3Health News:American Academy of Orthopaedic Surgeons 2011 Annual Meeting tip sheet 4Health News:American Academy of Orthopaedic Surgeons 2011 Annual Meeting tip sheet 5Health News:To increase physical activity, focus on how, not why 2Health News:2 Pesticides Linked to Parkinson's in Study 2Health News:Inexpensive rinsing effective at reducing post-op infection following joint replacement surgery 2Health News:Some Docs May Use Twitter for 'Unprofessional' Messages: Report 2
Our 2.5v Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
3.5v Ophthalmic Diagnostic Set with AutoStep Coaxial Ophthalmoscope, Spot Retinoscope, Rechargeable Handle, and Soft Case. High-quality eyecare from the preferred name in diagnostic instruments....
... are standard in all Welch Allyn ... students, the 18335-SDS combines the superior ... the superior illumination of the Halogen ... of the Finnoff Transilluminator, and the ...
High-quality eyecare from the preferred name in diagnostic instruments....
Medicine Products: